I also first bought in back in 2016. There's been a lot of change since then - some capital raises and a 20 to 1 consolidation. I paid as much as .015 cents back then - equivalent to 30 cents after the consolidation (that was in the days of the excellent Phase 2a results, and I don't think it got too much higher than that). So at last I'm in the green even on those.
Still, a good lesson of the need for patience with biotechs. And I'd reckon Dr Brad and OvF and stormer and other LTHs have been in DXB longer than I have.
Chartwatch - DXB, page-291
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.025(5.62%) |
Mkt cap ! $261.8M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 49.5¢ | 45.0¢ | $2.042M | 4.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98853 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |